| MGNX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MGNX shares outstanding history going back to 10/10/2013:
Also see: MGNX Market Cap History MGNX YTD Return |
MGNX Shares Outstanding History — MacroGenics Share Count Over Time
As of 5/8/2026 MacroGenics has 63.56 million MGNX shares outstanding. Investors often track the MGNX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MGNX share count trends over time, with 53 historical shares outstanding datapoints presented, dating back to 10/10/2013.
| MGNX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MGNX Historical Shares Outstanding: +8.41% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MGNX Stock Price Chart |
| About MacroGenics, Inc |
| MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is vobramitamab duocarmazine (vobra duo), an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. We show 53 historical shares outstanding datapoints in our coverage of MGNX's shares outstanding history. Understanding the changing numbers of MGNX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MGNX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MGNX by allowing them to research MGNX shares outstanding history as well as any other stock in our coverage universe. |
| MGNX Current Stock Quote |
Quotes delayed 20 minutes  Free MGNX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| MGNX Share Performance |
| Shares Outstanding Peers |
| MacroGenics (MGNX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MGRM Shares Outstanding History MGTA Shares Outstanding History MGX Shares Outstanding History MIRA Shares Outstanding History MIRM Shares Outstanding History MIRO Shares Outstanding History MLAB Shares Outstanding History MLND Shares Outstanding History MLNT Shares Outstanding History MLYS Shares Outstanding History More Healthcare companies » |
MGNX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
